STAT+: At MAHA Summit, a grassroots movement goes corporate
Federal officials and health care executives rubbed elbows at the ritzy MAHA Summit, causing some supporters to question what MAHA has become.
Martes 29 de septiembre de 2026 · 152 publicaciones en las últimas 24 h · 29 fuentes · actualizado hace 20 min
STAT: últimas publicaciones
Periodismo sobre salud, medicina y ciencias de la vida. Prensa médica · Estados Unidos · Sitio oficial.
20 notas · Solo en español
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining medicines from licensed international pharmacies.
STAT+: PhRMA taps Eric Cantor as new CEO
Eric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.
STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.
STAT+: Overton won’t get a vote before midterms
Health department nominees await Senate votes, and we map out what the elections mean for healthy policy.
STAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
In this edition of STAT Health Tech: Oura delays IPO plans, Anthropic joins an clinical AI effort by ARPA-H, and MAHA's health data goals.
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
AstraZeneca is teaming up with Summit Therapeutics to test its PD-1/VEGF bispecific ivonescimab alongside AstraZeneca’s antibody-drug conjugates.
STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
Novo has agreed to pay up to $2.6 billion to license an experimental, weekly weight loss pill from China’s Hengrui Pharma
Researchers slow neurodegeneration in mice by barring T cells from the brain
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.
STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.
Why MAHA wants to make health data much more accessible
At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study vaccines, chronic diseases, and autism
She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned
Jennifer Reich has spent two decades speaking to families about their immunization decisions. In an interview, she unpacks what she's learned.
STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.
STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms
Big shifts in health care policy could emerge depending on who wins the midterms, affecting hospitals and pharma companies.
Opinion: Child health is the national security crisis we keep ignoring
“National security begins in childhood,” write Tina L. Cheng, Stanley McChrystal, and James M. Perrin.
Opinion: Massive SNAP cuts could mean more children are separated from their families
"We should not make families poorer and then punish them for their poverty," write Sandy Santana and Kristen Weber of the National Center for Youth Law.
Risk from toxic metals can persist months after wildfires, Maui study finds
Post-wildfire air quality needs to be monitored long term, suggests a study finding Maui residents had high levels of toxic metals months later.
STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
Trump administration asks Supreme Court to allow transgender medical care restrictions in prison
The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care in federal prison.
STAT+: It really is bleak out there, and list prices matter
Health insurance premiums are skyrocketing, private equity hospital chain goes nonprofit, and more from STAT's Health Care Inc.
Mostramos el titular, un extracto breve y el enlace a cada nota; el contenido completo y sus derechos son de cada medio. Las notas se recogen automáticamente de los canales RSS públicos de las fuentes cada 30 minutos y se clasifican por especialidad con palabras clave, así que alguna puede quedar en una sección que no le corresponde. Una noticia no es una recomendación clínica: antes de cambiar una conducta, revisa el artículo original y las guías vigentes. ¿Eres editor de un medio y prefieres no aparecer? Escríbenos. Suscríbete por RSS.